Story perspectives

AlphaFold 3 Revolutionizes Drug Design and Protein Research

11/29/2025

Summary

Story summary

AlphaFold 2, developed by Google DeepMind, revolutionizes biochemical research by predicting protein structures from DNA sequences.
AlphaFold 2 was launched five years ago and has become essential for drug discovery, with over 3.3 million researchers and more than 200,000 publications.
AlphaFold 3, the model's successor, enhances drug design by predicting protein interactions.
Notable discoveries include the apoB100 protein structure, linked to heart disease.

1 of 1

Story summary

AlphaFold 2, developed by Google DeepMind, revolutionizes biochemical research by predicting protein structures from DNA sequences.
AlphaFold 2 was launched five years ago and has become essential for drug discovery, with over 3.3 million researchers and more than 200,000 publications.
AlphaFold 3, the model's successor, enhances drug design by predicting protein interactions.
Notable discoveries include the apoB100 protein structure, linked to heart disease.